author-photo

Renee Leduc

Harvard University

37

Papers

746

Citations

Citation Trend

Filter By

Papers (27) Sort By

Journal Conference Others

WMO—Better Service to All: A Leadership Town Hall on WMO Reform and Public–Private Partnerships

2021
Show All
- Source
- Cite
- Save
Citations (0)
The Wizard Behind the Curtain?—The Important, Diverse, and Often Hidden Role of Spectrum Allocation for Current and Future Environmental Satellites and Water, Weather, and Climate

2019
Show All
- Source
- Cite
- Save
Citations (0)
Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: a multicentre, phase 1/2, open-label, dose-escalation study.

2011 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (73)
Phase II Trial of Weekly Bortezomib in Combination With Rituximab in Relapsed or Relapsed and Refractory Waldenström Macroglobulinemia

2010 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (125)
The Role of Serum Immunoglobulin Free Light Chain In Response and Progression In Waldenstrom Macroglobulinemia

2010 Blood
Show All
- Source
- Cite
- Save
Citations (2)
The Role of PET Scan Imaging In Waldenstrom Macroglobulinemia

2010 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Phase II Trial of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Relapsed or Refractory Waldenström Macroglobulinemia

2010 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (132)
Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia

2010 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (98)
Final Results of the Phase I/II Trial of Weekly Bortezomib In Combination with Temsirolimus (CCI-779) In Relapsed or Relapsed/Refractory Multiple Myeloma Specifically In Patients Refractory to Bortezomib

2010 Blood
Show All
- Source
- Cite
- Save
Citations (6)
Serum Immunoglobulin Free Light Chain (sFLC) Measurement as a New Marker of Response to Therapy and Survival in Waldenstrom Macroglobulinemia (WM).

2009 Blood
Show All
- Source
- Cite
- Save
Citations (0)